161 EFFECT OF MELOXICAM TREATMENT ON PREGNANCY RATES IN HOLSTEIN HEIFERS

Abstract

We previously reported that administration of flunixin meglumine two times at a critical stage approaching pregnancy recognition associated with corpus luteum maintenance increased early embryo survival and pregnancy rate via an additive antiluteolytic effect with the conceptus (Guzeloglu et al. 2006 Reprod. Fertil. Dev. 18, 183). In this study, the objective was to determine if a single administration of meloxicam, a non-steroid anti-inflammatory drug (NSAID) with a longer half-life, could be used instead of flunixin meglumine to avoid repeated injections in heifers at a critical stage following insemination to increase pregnancy rate due to its inhibitory effect on PGF_2± synthesis. Eighty-five 15-18-month-old Holstein heifers were synchronized; following insemination (Day 0), the heifers were randomly assigned to receive a subcutaneous meloxicam injection (0.5 mg kg^-1; n = 37) in the afternoon of Day 15 or left untreated as controls (n = 48). Pregnancy rates were defined as the percentage of heifers diagnosed pregnant by ultrasound between Days 31 and 38 after AI. The effect of treatment on pregnancy rates was analyzed by chi-square test. Meloxicam treatment on Day 15 after insemination dramatically decreased the pregnancy rates in the heifers (25 of 48 (52%) in the control group vs. 9 of 37 (24.3%) in the meloxicam-treated group; P < 0.01). This result indicates that administration of meloxicam around a time associated with pregnancy recognition and corpus luteum maintenance was harmful to the pregnancy even though the drug is considered to be safe during pregnancy in cattle. It is concluded that direct or indirect effects of meloxicam on the uterine environment and/or embryo are not favorable at least during early pregnancy in cattle. How meloxicam exerted its detrimental effect on pregnancy warrants further investigation.